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Luke Piggott1,2†, Nader Omidvar1†, Salvador Martí Pérez2, Rhiannon French1, Matthias Eberl2
and Richard WE Clarkson1*Correction
While compiling the article [1] one of the authors was
inadvertently omitted from the author list. This author,
Rhiannon French, has been included in the corrected
author list above.
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